increased hemolymphoid system tumor incidence_Kmt2a<tm2(MLLT3)Thr>/Kmt2a<tm2(MLLT3)Thr>

http://metadb.riken.jp/0010296I129P2OlaHsdC57BL6FVBKmt2atm2MLLT3ThrKmt2atm2MLLT3ThrKmt2atm2MLLT3Thr

increased hemolymphoid system tumor incidence_Kmt2a<tm2(MLLT3)Thr>/Kmt2a<tm2(MLLT3)Thr>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• lysine (K)-specific methyltransferase 2A
  http://metadb.riken.jp/db/mgi_rdf/MGI:96995

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Kmt2a<tm2(MLLT3)Thr>/Kmt2a<tm2(MLLT3)Thr>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Kmt2a<tm2(MLLT3)Thr>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6 * FVB

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased hemolymphoid system tumor incidence
  http://purl.obolibrary.org/obo/MP_0010296

文献

http://purl.org/net/cito/citesAsAuthority

• Weili. Chen, et.al., A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy., Blood, 2006, 108
  http://rdf.ncbi.nlm.nih.gov/pubmed/16551973